Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy.

Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy.
复制标题

DOI:
10.1038/s41598-018-19146-y
复制
发表时间:
2018-01-15
期刊:
影响因子:
4.6
通讯作者:
Zhou LQ
Zhou LQ
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Peng D;Zhang CJ;Gong YQ;Hao H;Guan B;Li XS;Zhou LQ

文献摘要

参考文献

被引文献

相似文献

膀胱癌根治性膀胱切除术后的预后是不同的。我们旨在评估HALP(血红蛋白、白蛋白、淋巴细胞和血小板)对膀胱癌根治性膀胱切除术后患者预后的价值,并探索新的预后指标。本回顾性研究纳入516例膀胱癌根治性膀胱切除术后患者。中位随访时间为37个月(2 ~ 99个月)。总生存率降低的危险因素为年龄较大、TNM分期高、ASA分级高、HALP评分低。基于halp的nomogram预测准确率优于TNM分期(C- index 0.76±0.039 vs. 0.708±0.041)。结合ASA分级和HALP,我们创建了一个新的指标- HALPA评分,并发现它是降低生存率的独立危险因素(HALPA评分= 1,危险度1.624,95% CI 1.139-2.314, P = 0.007; HALPA评分= 2,危险度3.471,95% CI: 1.861-6.472, P < 0.001)。本研究确定了HALP的预后价值,并为膀胱癌根治性膀胱切除术后的HALPA评分提供了一种新的指标。
The outcome of bladder cancer after radical cystectomy is heterogeneous. We aim to evaluate the prognostic value of HALP (hemoglobin, albumin, lymphocyte and platelet) and explore novel prognostic indexes for patients with bladder cancer after radical cystectomy. In this retrospective study, 516 patients with bladder cancer after radical cystectomy were included. The median follow-up was 37 months (2 to 99 mo). Risk factors of decreased overall survival were older age, high TNM stage, high American Society of Anesthesiologists (ASA) grade and low HALP score. The predictive accuracy was better with HALP-based nomogram than TNM stage (C- index 0.76 ± 0.039 vs. 0.708 ± 0.041). By combining ASA grade and HALP, we created a novel index—HALPA score and found it an independent risk factor for decreased survival (HALPA score = 1, HR 1.624, 95% CI 1.139–2.314, P = 0.007; HALPA score = 2, HR 3.471, 95% CI: 1.861–6.472, P < 0.001).The present study identified the prognostic value of HALP and provided a novel index HALPA score for bladder cancer after radical cystectomy.
DOI: 10.1016/j.eururo.2016.06.020
发表时间: 2017-03-01
期刊: EUROPEAN UROLOGY
影响因子: 23.4
作者:
Witjes, J. Alfred;Lebret, Thierry;Ribal, Maria J.
通讯作者: Ribal, Maria J.
DOI: 10.2147/ott.s107445
发表时间: 2016
影响因子: 4
作者:
Ma C;Lu B;Diao C;Zhao K;Wang X;Ma B;Lu B;Sun E
通讯作者: Sun E
术前血红蛋白、白蛋白、淋巴细胞和血小板联合检测对胃癌患者的预后意义:一项回顾性队列研究。
DOI: 10.18632/oncotarget.5629
发表时间: 2015-12-01
期刊: Oncotarget
影响因子: --
作者:
Chen XL;Xue L;Wang W;Chen HN;Zhang WH;Liu K;Chen XZ;Yang K;Zhang B;Chen ZX;Chen JP;Zhou ZG;Hu JK
通讯作者: Hu JK
DOI: 10.1111/bju.12240
发表时间: 2014-06-01
期刊: BJU INTERNATIONAL
影响因子: 4.5
作者:
Djaladat, Hooman;Bruins, Harman Maxim;Daneshmand, Siamak
通讯作者: Daneshmand, Siamak
IgA 肾病肾小球衰老标志物的功能网络:新的治疗机会
DOI: 10.18632/oncotarget.9033
发表时间: 2016-06-07
期刊: Oncotarget
影响因子: --
作者:
Jiang H;Liang L;Qin J;Lu Y;Li B;Wang Y;Lin C;Zhou Q;Feng S;Yip SH;Xu F;Lai EY;Wang J;Chen J
通讯作者: Chen J